Sourasky Medical Center (Ichilov)
| Izrael | Turcja | Austria | |
| Immunoterapia Keytruda (Pembrolizumab) | od $9,800 | od $3,300 | od $15,000 |
| Chemioterapia w raku piersi | od $22,500 | od $1,200 | od $15,000 |
| Chemioterapia | od $2,400 | od $2,430 | od $2,500 |
| Terapia biologiczna | - | od $5,500 | od $20,000 |
| Radioterapia raka odbytnicy | - | od $7,000 | od $12,000 |
Kieruje Oddziałem Hematologii w Centrum Medycznym Sourasky, przewodząc zespołowi szpitalnemu w zakresie opieki nad pacjentami z nowotworami krwi.
Przeprowadził kilkaset przeszczepów komórek macierzystych — dr Ram specjalizuje się w złożonych przypadkach wymagających tej zaawansowanej procedury w Centrum Medycznym Sourasky.
Dr Ronit El Hasid wykonała ponad 300 przeszczepień szpiku kostnego i krwi pępowinowej u dzieci. Kieruje ona oddziałem w Szpitalu Dziecięcym im. Dana Dwek w Centrum Medycznym Sourasky.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.